AMBG P/L
Qual é o P/L de AMBG?
O P/L de AMBG Inc. é N/A
Qual é a definição de P/L?
A razão entre preço e lucro é a razão entre o preço das ações de uma empresa e o lucro por ação da empresa, calculado ao longo de doze meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/L de empresas na Setor Finance em OTC em comparação com AMBG
O que AMBG faz?
AMBG INC. intends to seek new business opportunities or to engage in a merger or acquisition with an unidentified company. Previously, it was intended to specialize in historical and cultural media, operating a content network throughout the United States and Europe for marketing, advertising, public relations, communications, television broadcasting, DVDs, books, e-books, enhanced e-books, and traditional magazines. The company was formerly known as Wordsmith Media, Inc. AMBG INC. was incorporated in 2005 and is based in New York, New York.
Empresas com p/l semelhantes a AMBG
- Canadian Orebodies tem P/L de N/A
- Shirpur Gold Refinery tem P/L de N/A
- Miniluxe Corp tem P/L de N/A
- Canyon Creek Food tem P/L de N/A
- True North Gems tem P/L de N/A
- Starlite Components tem P/L de N/A
- AMBG tem P/L de N/A
- Verde Bio Hldgs Inc tem P/L de N/A
- Oncopeptides AB (publ) tem P/L de N/A
- Syros Pharmaceuticals tem P/L de N/A
- Far East International tem P/L de N/A
- Puma VCT 11 tem P/L de N/A
- Altair Resources tem P/L de N/A